The preventive therapy is the first-ever proven against bovine anaplasmosis, which costs the global cattle industry $1 billion, annually. University of Missouri (MU) researchers have created the first vaccine proven to protect cattle from bovine anaplasmosis.1 The vaccine was the product of a study led by Roman Ganta, a McKee endowed professor in UM’s College of Veterinary Medicine, and Bond Life Sciences Center researcher. In the study, researchers genetically modified the pathogen that causes bovine anaplasmosis, Anaplasma marginale. Deleting a specific gene, then injecting the modified pathogen into the cattle, left the vaccinated cattle immunized against the disease.1.